Senior Director, Global Medical Immunology & Cardiovascular, Milvexian Medical Strategy (MD/DO required) at Bristol-Myers Squibb

Princeton, New Jersey, United States

Apply Now

Not SpecifiedCompensation

Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceuticals, Biotechnology, HealthcareIndustries

Requirements

MD/DO required (Clinical Cardiology/Thrombosis Medical affairs experience preferred)
Ability to speak English
Familiar with all phases of drug development
Healthcare landscape knowledge & insight
Proven impact and influence with high impact national thought leaders
Excellent analytical skills demonstrated ability to identify and understand complex issues and problems and identify and query key findings from study data and publications
Organized, attention to detail and ability to meet timelines in a fast-paced environment
Experience in developing effective abstracts, manuscripts, posters and slides, and presenting at scientific meetings
Ability to work on multiple projects simultaneously

Responsibilities

Support the execution of Global medical plan that is both product and disease specific, translating commercialization and medical strategies into effective milvexian medical launch plans and life cycle management plans
Work with cross-functional matrix and alliance partners on a variety of projects, provide independent thought and initiative in the further development of specific projects and ensuing presentations and status updates
Identify Medical data generation strategies, collaborate with Medical Evidence Generation (MEG) to review and oversee execution of the Investigator Sponsored Research (ISR) programs
Provide strategic input in Phase IIIb/IV trials and real-world evidence programs across Global Medical Affairs
Review and develop study concepts, protocols and reports aligned with integrated evidence generation plans
Attend major conferences and help coordinate medical affairs activities at conferences
Responsible for the development and execution of projects that will provide more extensive background, and additional data/answers to questions in response to issues relative to commercial, scientific, or data needs
Serve as medical strategy point on select scientific issues/topics using expertise to develop scientific messages, inform strategy, create/update slide decks, and review scientific content and publication
Collaborate with the Executive Director, Medical Product Lead and medical matrix in the development of Customer Impact Plan and ensure alignment of team activities
Regular communication with external thought leaders and internal field team to identify key insights and to provide medical education, support, and direction as appropriate
Partner closely with colleagues in Discovery, Clinical Research, Regulatory, and Health Outcomes to ensure the science of the pipeline products and marketed medicines are understood and communicated properly internally and externally

Skills

Medical Strategy

Thrombosis

Immunology

Cardiovascular

Milvexian

Global Medical Plan

Investigator Sponsored Research

Phase IIIb/IV Trials

Cross-Functional Collaboration

Disease State Knowledge

Bristol-Myers Squibb

Develops and delivers biopharmaceutical medicines

About Bristol-Myers Squibb

Bristol Myers Squibb (BMS) develops and delivers medicines aimed at treating serious diseases, focusing on areas like cancer, autoimmune diseases, and heart conditions. The company conducts extensive research and development to create new drugs, which are sold after receiving regulatory approval. BMS also produces generic drugs, offering affordable alternatives that meet the same quality standards as their branded counterparts. What sets BMS apart from competitors is its dual focus on both innovative and generic medicines, enhancing access to healthcare. The company's goal is to improve patient outcomes while maintaining a commitment to sustainability and corporate responsibility.

New York City, New YorkHeadquarters

1887Year Founded

$33,706.1MTotal Funding

IPOCompany Stage

Biotechnology, HealthcareIndustries

10,001+Employees

Benefits

Flexible Work Hours

Hybrid Work Options

Professional Development Budget

Risks

Increased competition in oncology from emerging biotech firms like ArsenalBio.

BMS's lawsuit over the 340B Drug Pricing Program may lead to regulatory challenges.

Rapid AI and digital tech evolution may pose integration challenges for BMS.

Differentiation

BMS focuses on innovative cancer treatments through collaborations like ArsenalBio for T cell therapies.

The company emphasizes digital health technologies, enhancing clinical trial management and patient engagement.

BMS offers both innovative and generic medicines, increasing affordable healthcare solutions.

Upsides

BMS's partnership with Medidata enhances clinical research processes and patient outcomes.

The collaboration with AI Proteins advances novel miniprotein-based therapeutics, expanding therapeutic modalities.

BMS's global license agreement with BioArctic expands its portfolio in neurodegenerative diseases.

Land your dream remote job 3x faster with AI

Try Jobo Free